Architecture of mTOR protein complex solved

December 17, 2015
3-D model of the protein complex mTORC1. Credit: University of Basel, Biozentrum

For a long time it has been known that the protein TOR - Target of Rapamycin - controls cell growth and is involved in the development of diseases such as cancer and diabetes. Researchers at the University of Basel's Biozentrum together with scientists from ETH Zurich have now examined the structure of mammalian TOR complex 1 (mTORC1) in more detail. The scientists have revealed its unique architecture in their latest publication in Science.

About 25 years ago, Prof. Michael Hall discovered the protein "Target of Rapamycin" (TOR) at the Biozentrum. It is one of the most studied proteins of the protein kinase family, an important family of regulatory proteins that control many cellular processes. TOR, in mammals called mTOR, is very important for cellular signalling and is implicated in various diseases such as cancer, diabetes, and neurodegeneration. Several mTOR inhibitors have already been approved for therapeutic use, in particular in the treatment of cancer and allograft rejection.

However, despite extensive research on TOR over the last decades, attempts to uncover the detailed structure of the protein kinase and its partners have been unsuccessful. By combining crystallographic methods with cryo-electron microscopy, Prof. Timm Maier's team together with researchers of the ETH Zurich have now been able to provide unprecedented insight into the architecture of the protein complex mTORC1.

Structure of mTORC1 elucidated

In the cell, the protein kinase mTOR is found in two structurally and functionally distinct protein complexes termed mTORC1 and mTORC2 in mammals. Both complexes are giant protein structures consisting of mTOR and other accompanying proteins. In these two configurations the carries out various functions such as the control of cell size and growth, as well as the regulation of metabolism and energy balance.

mTOR itself is one of the largest proteins in the cell and when combined with other proteins even larger. This makes it quite difficult to investigate its structure. "The partner proteins of mTOR have already been identified in earlier biochemical studies", says Maier. "However, it has remained unclear how the proteins interact precisely." After more than three years of work, the scientists led by Maier have succeeded in isolating mTORC1 in the quality required for high-resolution . Using X-ray crystallography they have also been able to determine the structure of the protein Raptor, the second major component of mTORC1.

Accompanying proteins important for function

"Although there is much known about mTORC1, our study revealed surprising new insight", states Maier. "The architecture of this huge protein complex is quite exceptional. We could determine the precise interaction sites of the partner proteins and how they are arranged, and thus elucidate the function of the individual partners." In fact, each protein plays an important role in the regulation of the activity of the entire complex and the intracellular signalling cascade.

More than the sum of its parts

With their study, the researchers have provided the basis for further investigations. Now the researchers will be able to investigate the function of each individual in the complex in more detail. "But it doesn't make sense to examine the individual components alone, as the interactions of all the proteins in the complex are critical for its function", explains Maier. "The whole is much more than the sum of its parts." The finely tuned regulation of mTOR activity is very important because even the smallest disturbances can have serious consequences. Thus, dysregulation in the mTOR signalling pathways plays a role in the development of a number of diseases.

Explore further: Aberrant mTOR signaling impairs whole body physiology

More information: "Architecture of human mTOR Complex 1" Science, DOI: 10.1126/science.aaa3870

Related Stories

Aberrant mTOR signaling impairs whole body physiology

August 11, 2014

The protein mTOR is a central controller of growth and metabolism. Deregulation of mTOR signaling increases the risk of developing metabolic diseases such as diabetes, obesity and cancer. In the current issue of the journal ...

The pertussis pathogen—new findings

June 23, 2015

The worldwide spreading of the whooping cough, also known as pertussis, has substantially increased since 2010. Researchers from the Biozentrum, University of Basel, have investigated structure and function of an important ...

Recommended for you

Sea sponges stay put with anchors that bend but don't break

June 22, 2017

Sea sponges known as Venus' flower baskets remain fixed to the sea floor with nothing more than an array of thin, hair-like anchors made essentially of glass. It's an important job, and new research suggests that it's the ...

Custom-built molecule shows promise as anti-cancer therapy

June 22, 2017

Scientists at the University of Bath funded by Cancer Research UK have custom-built a molecule which stops breast cancer cells from multiplying in laboratory trials, and hope it will eventually lead to a treatment for the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.